New York, United States
Proliv Mcpy offers the Proliv®Rx System, an FDA-approved neuromodulation therapy for treating Major Depressive Disorder in adults who have not responded adequately to antidepressant medication. The system provides focal external Combined Occipital and Trigeminal Afferent Stimulation (eCOT-AS) treatment intended as an adjunctive home-based or clinic-based therapy. Proliv®Rx is designed for health systems and VA VISNs to deliver a scalable next-step therapy without adding clinics, staff, or operational burden. The treatment involves a structured 8-16 week program with continuous physician direction and adherence tracking. Patients have demonstrated significant improvement in depression severity, with 87% showing measurable impact. Proliv®Rx is estimated to save $35K per patient annually through reduced escalation to in-clinic treatments and emergency room visits.
Browsing, company names, locations and sectors are always free. A free account adds 5 contact releases every month — e-mail and phone, view or export. Need more? Contact packs start at 19 € for 50, or upgrade to a monthly plan.
Yes — no card required. Browsing is always free, and a free account adds 5 contact releases every month.
Your first 5 contact releases each month are included in the free account. After that, packs start at 19 € for 50 contacts (view or export), or a monthly plan for regular use.
Companies are harvested from the open web — registers, websites and industry directories — not self-registered sign-ups. Contact details are shown only once you use a release or credit, never invented.